Stock ScreenerStock IdeasBest Value Stocks to Buy Now
Best Value Stocks to Buy Right Now (2026)
A list of the best value stocks to buy right now, based on the proven Zen Ratings quant model. "A" Rated stocks averaged +32.52% return. Learn More

Zen Rating: A + 1 more
Value Rating: A + 1 more
Ticker
Company
Zen Rating
Financials
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
EMBC
EMBECTA CORP
AA$546.01M-20.90%12.60%36.12%14.40%-2.742.6463.10%12.90%27.73%
HLF
HERBALIFE LTD
AA$1.71B-36.20%8.40%27.64%15.40%-6.401.1377.90%4.50%9.73%
IRWD
IRONWOOD PHARMACEUTICALS INC
BA$640.82M-8.20%6.60%66.44%16.30%-2.521.13100.00%8.10%34.70%
CCSI
CONSENSUS CLOUD SOLUTIONS INC
BB$504.18M-522.60%13.00%24.99%21.00%47.201.7979.80%24.20%42.76%
PRGS
PROGRESS SOFTWARE CORP
BB$1.15B17.80%3.50%10.35%15.50%3.800.4781.20%8.60%16.84%
VNT
VONTIER CORP
BA$5.12B34.00%9.30%18.44%20.90%2.511.1647.20%13.20%18.47%
TOYO
TOYO CO LTD
AB$439.89M46.50%11.60%40.04%34.40%2.970.5822.50%9.30%13.65%
AFYA
AFYA LTD
AC$1.31B16.20%8.20%16.59%33.50%0.922.2064.50%20.40%38.03%
TASK
TASKUS INC
AB$586.84M18.30%10.00%17.47%26.50%0.753.1237.80%8.60%13.10%
INCY
INCYTE CORP
BA$18.84B29.10%20.70%30.63%77.30%0.353.3292.80%25.00%32.42%
AUNA
AUNA SA
AC$384.87M6.30%1.40%14.87%13.70%3.461.1137.90%2.20%19.09%
BHC
BAUSCH HEALTH COMPANIES INC
BC$2.09B-20.50%0.60%9.05%7.80%-46.911.4770.70%1.50%19.56%
EXEL
EXELIXIS INC
BA$11.67B36.90%28.00%38.59%42.20%0.323.5696.40%33.70%40.57%
REPX
RILEY EXPLORATION PERMIAN INC
BA$761.33M28.10%14.70%23.72%19.40%0.840.6070.30%41.00%61.31%
VEON
VEON LTD
BC$3.92B43.60%6.20%21.81%18.60%5.660.9188.00%12.10%28.67%
USNA
USANA HEALTH SCIENCES INC
BC$358.80M2.00%1.50%6.78%23.30%0.292.2478.30%1.20%4.50%
COLL
COLLEGIUM PHARMACEUTICAL INC
BA$1.03B24.10%3.90%14.38%19.10%4.491.5759.30%8.10%22.41%
MSGM
MOTORSPORT GAMES INC
AA$23.63M153.10%76.40%77.91%-659.10%0.652.2581.50%61.30%59.32%
UPWK
UPWORK INC
BB$1.39B18.80%9.00%23.59%21.00%1.061.4677.80%14.70%19.44%
PBI
PITNEY BOWES INC
AB$2.34B-22.80%4.50%18.13%10.60%-4.950.7154.10%7.60%15.53%
NMM
NAVIOS MARITIME PARTNERS LP
AC$2.02B8.80%4.90%7.67%5.60%0.781.1361.90%21.20%31.26%
LDOS
LEIDOS HOLDINGS INC
BB$18.46B30.90%10.80%19.67%25.40%1.741.7018.00%8.40%12.22%
OTEX
OPEN TEXT CORP
BC$5.62B10.90%3.20%7.56%11.70%2.360.9472.70%8.40%16.15%
EVER
EVERQUOTE INC
BA$572.15M54.20%37.60%25.79%339.10%0.372.9497.20%14.30%8.93%
NEXA
NEXA RESOURCES SA
AC$1.91B14.20%2.70%14.39%12.60%3.970.8723.70%4.40%18.25%
VLGEA
VILLAGE SUPER MARKET INC
AB$625.48M11.40%5.60%10.23%8.50%0.991.2328.30%2.40%3.58%
CNMD
CONMED CORP
AC$1.18B4.70%2.00%5.08%7.10%1.252.1454.60%3.40%7.43%
PRG
PROG HOLDINGS INC
BA$1.24B21.20%9.70%N/A15.20%1.16N/A34.00%6.10%9.51%
BFH
BREAD FINANCIAL HOLDINGS INC
BC$3.71B16.10%2.30%N/A2.80%5.81N/A100.00%19.90%23.51%
AYI
ACUITY INC (DE)
BA$8.78B15.70%9.20%14.96%30.50%0.612.0748.70%9.40%12.49%
FIVN
FIVE9 INC
AB$1.27B5.40%2.10%3.74%3.40%1.284.5155.10%3.40%5.14%
DDI
DOUBLEDOWN INTERACTIVE CO LTD
BB$443.50M11.30%10.30%15.09%116.30%0.107.7471.80%28.50%40.75%
SHIP
SEANERGY MARITIME HOLDINGS CORP
AC$295.39M7.80%3.70%8.29%5.90%1.160.8562.50%13.40%27.17%
NRDS
NERDWALLET INC
AA$726.63M12.70%10.20%17.63%45.00%0.233.4592.40%5.80%8.22%
CI
CIGNA GROUP
BB$72.64B14.50%3.90%8.72%17.80%2.780.859.30%2.20%3.22%
TEX
TEREX CORP
BC$7.12B11.20%3.60%9.47%9.80%1.932.3019.40%4.10%8.65%
GILD
GILEAD SCIENCES INC
AA$161.88B41.00%14.80%22.92%29.30%1.601.5578.80%28.90%36.75%
FMS
FRESENIUS MEDICAL CARE AG
BC$12.72B7.30%3.10%6.80%7.70%1.261.2725.60%5.00%8.58%
YEXT
YEXT INC
BB$476.11M24.90%6.40%14.68%42.80%2.901.0774.50%8.50%10.68%
OPBK
OP BANCORP
BC$213.68M11.70%1.00%N/A1.40%10.63N/A100.00%28.10%38.78%
FVRR
FIVERR INTERNATIONAL LTD
BB$384.03M5.30%2.10%5.37%7.20%0.661.9381.60%4.90%5.43%
PRDO
PERDOCEO EDUCATION CORP
BB$2.02B16.30%12.50%20.12%32.90%0.285.0676.70%18.90%26.39%
INVA
INNOVIVA INC
AA$1.75B30.60%19.20%21.67%35.20%0.3914.6474.80%65.90%83.52%
OSPN
ONESPAN INC
BB$424.88M29.60%20.40%17.43%71.40%0.461.5073.80%30.00%20.30%
OPY
OPPENHEIMER HOLDINGS INC
AB$1.11B16.20%4.00%N/A5.90%2.77N/A98.30%9.10%18.20%
HRTG
HERITAGE INSURANCE HOLDINGS INC
BC$899.20M47.30%8.40%N/A14.20%3.35N/A63.00%23.10%31.53%
BCRX
BIOCRYST PHARMACEUTICALS INC
AA$2.24B-76.50%55.60%108.86%39.00%-5.322.0697.80%30.20%39.58%
TXT
TEXTRON INC
BC$15.32B12.20%5.30%9.15%9.80%1.301.8218.20%6.20%8.52%
TDC
TERADATA CORP
AA$2.44B66.40%7.40%23.58%35.80%6.740.9259.40%7.80%12.27%
STRA
STRATEGIC EDUCATION INC
BC$1.66B7.90%6.20%9.79%58.30%0.271.1649.30%10.20%13.98%
UHS
UNIVERSAL HEALTH SERVICES INC
BC$10.65B21.10%9.80%17.14%15.70%1.131.0543.00%8.60%12.13%
PARR
PAR PACIFIC HOLDINGS INC
AB$3.15B28.80%9.50%20.62%13.80%1.551.6118.10%4.90%7.54%
RNG
RINGCENTRAL INC
AA$3.44B-8.10%2.80%44.34%9.50%-3.180.6371.20%1.70%4.63%
OSK
OSHKOSH CORP
BC$9.40B14.60%6.50%12.91%15.60%1.221.9417.50%6.20%9.17%
NBIX
NEUROCRINE BIOSCIENCES INC
AA$12.81B16.70%11.60%18.14%20.00%0.423.3998.20%16.70%24.66%
SBH
SALLY BEAUTY HOLDINGS INC
BB$1.43B23.40%6.50%13.14%9.90%2.462.3751.70%4.90%8.19%
CF
CF INDUSTRIES HOLDINGS INC
BA$18.58B30.00%10.50%15.54%17.80%1.313.3738.50%20.50%28.95%
OPRX
OPTIMIZERX CORP
AA$120.64M4.20%3.00%7.87%25.70%0.383.0467.30%4.70%11.19%
MLCO
MELCO RESORTS & ENTERTAINMENT LTD
BC$2.29B-13.90%2.40%10.18%5.50%-6.821.0737.50%3.60%12.64%
BLKB
BLACKBAUD INC
BB$1.72B146.30%5.00%16.53%52.00%27.110.7958.80%10.20%17.70%
CPRX
CATALYST PHARMACEUTICALS INC
BA$3.34B24.30%21.20%29.63%308.40%0.166.0885.20%36.40%48.14%
CARS
CARSCOM INC
BB$653.80M4.20%1.90%6.82%9.80%1.251.8782.90%2.80%8.94%
MRK
MERCK & CO INC
BC$276.66B36.20%14.60%20.65%26.10%1.601.5474.80%28.10%34.48%
UGP
ULTRAPAR HOLDINGS INC
BC$6.22BN/AN/AN/AN/AN/AN/A7.30%1.80%4.24%
PBYI
PUMA BIOTECHNOLOGY INC
AB$383.61M27.80%15.40%31.40%62.00%0.662.0074.50%13.60%18.57%
PD
PAGERDUTY INC
BB$605.90M77.20%18.10%4.32%4.90%2.842.0284.90%35.30%6.03%
HAE
HAEMONETICS CORP
BC$2.79B20.30%7.10%12.87%14.10%1.731.7559.40%13.30%19.05%
GRFS
GRIFOLS SA
BC$5.56B7.20%2.00%6.45%6.50%2.302.5138.00%5.30%15.18%
OGC
OCEANAGOLD CORP
AB$7.38BN/AN/A32.61%N/A0.391.4559.70%33.20%47.37%
BMY
BRISTOL MYERS SQUIBB CO
AB$119.56B39.30%7.50%14.00%15.30%3.871.2671.10%14.60%19.35%
PHIN
PHINIA INC
BC$2.79B8.20%3.40%9.72%10.80%1.411.8621.90%3.70%8.01%
RILY
BRC GROUP HOLDINGS INC
BB$268.55M-93.50%18.60%N/A16.40%-10.65N/A70.60%30.90%40.93%
TREE
LENDINGTREE INC
BA$668.68M94.40%18.70%9.44%11.70%1.981.6796.20%13.50%6.07%
KTB
KONTOOR BRANDS INC
AB$4.02B45.10%9.20%18.14%16.10%3.571.8245.20%7.20%11.45%
PCRX
PACIRA BIOSCIENCES INC
BB$1.05B0.90%0.50%3.00%3.10%0.834.5479.40%1.00%4.72%
SON
SONOCO PRODUCTS CO
BC$4.78B31.80%8.40%16.45%15.70%2.081.0520.90%13.30%18.89%
GASS
STEALTHGAS INC
BC$338.37M9.10%8.50%9.11%10.10%0.039.3053.80%35.00%36.32%
MU
MICRON TECHNOLOGY INC
AA$560.17B40.80%27.70%32.48%37.10%0.402.9058.40%41.50%48.74%
PAHC
PHIBRO ANIMAL HEALTH CORP
AC$2.24B30.80%6.70%14.96%10.10%3.233.0531.90%6.30%11.47%
DSX
DIANA SHIPPING INC
BC$282.52M2.40%1.00%5.62%3.70%1.332.7356.60%5.60%28.46%
TTEC
TTEC HOLDINGS INC
BC$150.55M-85.50%-11.70%-9.27%-6.80%14.581.8921.80%-9.00%-4.96%
IAG
IAMGOLD CORP
AA$10.19B18.20%12.10%19.01%17.60%0.381.7542.30%23.30%35.55%
GFI
GOLD FIELDS LTD
BA$40.94B52.30%28.10%N/A36.90%0.78N/A57.90%40.80%60.99%
IBEX
IBEX LTD
AB$379.51M31.90%15.70%26.15%22.60%0.911.8330.40%7.30%9.07%
ADBE
ADOBE INC
BA$99.16B62.30%24.80%50.44%134.50%1.600.9189.40%29.50%37.78%
MRP
MILLROSE PROPERTIES INC
BC$5.10B6.90%4.80%N/A5.40%0.58N/A85.40%67.40%86.12%
VVX
V2X INC
AC$1.97B7.30%2.50%7.98%14.80%2.031.228.30%1.70%4.04%
BTG
B2GOLD CORP
BB$6.66B12.10%7.30%20.54%20.90%0.621.0650.00%13.10%32.33%
BDC
BELDEN INC
BB$5.21B19.10%7.00%11.01%13.20%1.801.9438.00%8.70%11.54%
COHN
COHEN & CO INC
AC$53.57M31.30%1.60%N/A1.30%11.70N/A100.00%5.20%7.14%
ANIP
ANI PHARMACEUTICALS INC
BB$1.76B16.20%5.60%9.97%12.30%1.662.7161.40%8.70%13.11%
APA
APA CORP
BA$13.33B24.50%8.00%17.42%13.40%1.770.8338.60%15.60%28.70%
PBR
PETROBRA
BC$134.49B29.20%9.70%16.65%13.70%1.940.7147.60%22.00%34.78%
PMTS
CPI CARD GROUP INC
AB$208.24M-58.80%3.80%16.95%10.40%-24.262.4431.30%2.80%9.95%
FLXS
FLEXSTEEL INDUSTRIES INC
BB$258.14M17.70%10.90%17.92%17.40%0.573.4423.20%6.80%9.07%
UPBD
UPBOUND GROUP INC
BC$1.15B10.70%2.30%N/A5.50%3.71N/A48.40%1.60%4.71%
ERO
ERO COPPER CORP
BB$2.85B31.40%14.50%21.71%16.80%1.051.0643.90%33.60%45.95%
MD
PEDIATRIX MEDICAL GROUP INC
AB$1.91B19.60%7.70%14.12%28.30%1.601.6625.80%8.60%13.19%
ZTS
ZOETIS INC
BB$49.33B58.20%18.10%27.07%25.70%3.643.0371.80%28.20%37.84%
TNK
TEEKAY TANKERS LTD
BB$2.62B18.40%16.60%16.62%27.30%0.107.9836.60%36.90%36.79%

Upgrade to Premium to View More

Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More

Already have access to Premium? Sign In

Find the Best Value Stocks to Buy Now 

Value stocks represent the opportunity to buy shares of solid, reliable companies at a great price.

Traditionally, value stocks are associated with large, established companies trading at lower valuations relative to fundamentals. These companies typically have strong financials but may be temporarily undervalued due to things like market sentiment, a reaction to recent earnings, or economic cycles.  

However, you shouldn't just buy stocks because they look "cheap." What appear to be the best value stocks right now based on stock price alone might not have staying power. Locating high-quality value stocks for the long term requires research and due diligence. 

Keep reading to learn:

  • Common characteristics of the top value stocks 
  • How to avoid value investing pitfalls like “value traps”
  • How to locate stocks to buy that align with your investment strategy and goals 

Before we dive in, let’s take a step back and discuss what makes a stock a “value stock” and why some stocks trade at a discount in the first place.

What is a Value Stock? 

A value stock is a stock that appears undervalued based on fundamental metrics such as the price-to-earnings (P/E) ratio, price-to-book (P/B) ratio, or dividend yield.

For example, if a company’s book value is $50 per share, calculated by dividing its market capitalization by outstanding shares, but the stock trades at $45, analysts may see it as a value opportunity.

Value stocks are typically associated with high quality companies with stable earnings growth. Many, but not all, value stocks pay dividends. This is in contrast to growth stocks, which aim for rapid expansion and earnings growth and to outperform the market or their industry or sector. 

Value stocks also typically have lower potential returns but experience less volatility than growth stocks. Value investors buy stocks expecting their price to rise as the market recognizes their true value.

What are Classic Valuation Metrics?

Here are some of the most common metrics used to determine whether a stock is overvalued, fairly valued, or undervalued:

  • Price-to-Earnings (P/E) Ratio: Compares how much you are paying per dollar the company earns. It’s calculated by dividing the stock price by earnings per share (EPS).
  • Price-to-Book (P/B) Ratio: Compares a stock's price to its book value per share, which can be useful for evaluating asset-heavy companies.
  • Price-to-Sales (P/S) Ratio: Compares a company's stock price to its revenue per share, often used for companies with low or no earnings.
  • Dividend Yield: For stocks that pay dividends, this calculates dividend payments as a percentage of the stock price. Dividend yield is particularly relevant for income-focused investors.

However, that leads to an important point — simply relying on traditional value metrics may not be enough to identify the best opportunities. That brings us to important considerations you should know about value stocks…

Important Considerations for Value Stocks 

1. Classic Value Metrics May Not Be Enough 

The stock market has changed in the past few years. Experienced portfolio managers no longer make the majority of decisions or even buy stocks. Algorithmic trading now dominates Wall Street, with most institutional trades executed by quantitative models.

Early on, these models leveraged traditional value metrics such as price-to-earnings (P/E), book value, PEG ratio, and dividend yield if the company pays dividends. However, after years of relentless high-volume trading, the effectiveness of individual value metrics has diminished.

The real edge now comes from combining multiple factors to maximize the probability of success — just like the 21 Value metrics built into our proprietary Zen Ratings model.

Each of these 21 Value metrics has been rigorously tested and shown to identify stocks that consistently outperform the stock market and have ample room to grow. While the advantage of any single metric may be small, stacking 21 independent value criteria together significantly strengthens the odds of long-term outperformance. These include: 

  • Estimated Earnings Yield: Measures projected earnings against the stock’s current price.
  • EBIT/Enterprise Value: Evaluates operating income in relation to the company's overall worth.
  • Cash Flow Yield: Analyzes how a company’s cash flow compares to its market price.
  • Free Cash Flow to Price: Examines how a company’s valuation aligns with its free cash flow generation.
  • P/E Growth (PEG ratio): Adjusts the P/E ratio by factoring in expected growth.

2. Avoid Value Traps 

Many investors get so focused on specific value metrics like a low P/E ratio that they’re blinded to major red flags. 

Stocks with a low P/E ratio can be appealing, but it’s important to consider why it’s so low. Value traps occur when investors fail to recognize that a low P/E may signal a deteriorating earnings outlook. It can be a sign that a company is on a downward trajectory. 

The best way to avoid value traps? Look at more than just value to ensure that you invest in financially strong, growing companies.

Zen Ratings helps you look at value and beyond in stocks by evaluating 26 financial strength factors and 22 growth factors. Companies that earn A or B ratings in these categories provide strong evidence of sound, solid fundamentals throughout.

By taking this comprehensive approach, the odds of selecting companies with improving earnings prospects increase significantly, leading to more earnings beats and higher stock prices.  

3. Lack of Timeliness 

Value investing is considered a contrarian investing style because in essence, you are betting on companies that are currently out of favor on Wall Street.

Unfortunately, that can take time, and it can hinder your return on investment (ROI). 

Happily, Zen Ratings can help you gain a bigger-picture view. In addition to 21 Value Factors, it also zeroes in on 23 different factors that greatly increase the timeliness and ROI of your stocks — namely, 22 Momentum Factors and one AI Factor

Our Momentum models review a combination of short-term, medium-term, and long-term measures of positive price action that increase the odds the stock will stay in favor. Our Artificial Intelligence factor employs sophisticated cross-validation techniques, functioning as an internal system of checks and balances to ensure it isn't just fine-tuned for past performance but remains adaptable to future market conditions.

This approach prevents overfitting, meaning the AI doesn’t just excel in specific historical scenarios — it learns to recognize patterns that apply across various market environments, enhancing its long-term reliability.

The Bottom Line on Value Stocks 

For long-term investors, locating great value stocks requires a big-picture approach — and perhaps counterintuitively, the ability to look beyond just the intrinsic value alone. That’s because valuation is only one aspect of a stock’s bigger picture.

Yes, value investors — or really, anyone who doesn’t want to overpay for stocks — should attempt to select not only stocks that have an overall A or B Zen Rating but those with an A or B Value rating. Our Best Value Stocks to Buy Now Screener can help you quickly sift through the stocks with the highest Value ratings. 

However, our Zen Ratings system allows you to look at more than just value. In addition to seeing how a stock fares for Value, you can also see its prospects for Growth, Financials, Momentum, AI, and more. 

And if you’re struggling to locate Strong Buy value stocks? Our Zen Investor portfolio includes hand-selected stock picks that all have A or B Zen Ratings — A-rated stocks have historically generated an average return of 32.52%, while B-rated stocks have historically generated 19.88% returns. Gain access to the market-beating Zen Investor portfolio now


WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.